This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

A growing number of physicians are starting to shift their thinking about multiple myeloma’s prognosis. For years, patients have been told that multiple myeloma is treatable but not curable. Yet data ...

When Filippo Milano, MD, PhD, left his home in Italy in 2008 to further specialize in allogeneic transplantation in Seattle, it was supposed to be short-term. He would just stay long enough to learn ...

Over the years our annual Pathways to Health Symposium has hosted researchers and community champions to discuss important topics related to cancer health disparities. The Symposium provides a forum ...

The esophagus is the organ in the throat that moves food from the mouth to the stomach. Esophageal cancers make up approximately 1% of cancer diagnoses in the U.S., making them rare. Because many ...

Alt text provides a textual description of an image. It is crucial for users who are blind, visually impaired, or rely on assistive technologies. Well-written alt text enhances inclusivity and ensures ...

8:30 a.m.–9:20 a.m. Check-in for the day and connect with fellow STTR members and guests! The confluence of technological advances and social policies has led to rapid digitization of multimodal, ...

Direct Costs are expenses directly associated with a specific research project, including lab supplies, equipment, and project-related researcher salaries. Indirect costs refer to the shared ...

The androgen receptor (AR) is the central therapeutic target in advanced prostate cancer. While treatments that directly target AR are effective in prolonging patient survival, aggressive prostate ...

Dr. Kara Cicero is a hematologist-oncologist focused on global oncology and cancer disparities research to advance health equity, with specific clinical expertise in multiple myeloma, AL amyloidosis ...